[Characteristics of Low-Level Persistent viraemias in HIV-1 Patients Treated with Second-Line ARVs at the Sourô Sanou Teaching Hospital of Bobo-Dioulasso (Burkina Faso)]

We describe the characteristics of patients infected with HIV-1 as second-line antiretroviral therapy, with persisting low-level viremia. This was a descriptive retrospective study, conducted from January 1, 2010 to December 31, 2016, from the Cohort of the Infectious Diseases Department of Bobo-Dioulasso University Hospital. Patients infected with HIV-1, a second line of stable ARV treatment, with ≥95% compliance for at least 12 months, asymptomatic with CVp between 50 and 1000 copies/ml in two consecutive samplings at least 3 months apart. Out of 244 patients in second-line therapy, 79 met our inclusion criteria. The mean age of the patients was 42±10.2 years. Women (35.8 years) were younger than men (43.8 years) (p=0.001). Most were married (48.1%), 23.5% of whom were polygamous. The majority of patients (38/79) in the study had a CD4 count of <200 cells/ mm³. The median duration of ARV therapy since the beginning of the therapeutic history has been 4.8 (2.5-11 years). CVp greater than 10,000 copies/ml at the start of second-line therapy (p=0.003) and TDF+FTC + DRV + RTV combination (p=0.001) were associated with persistent low viremia. A genotypic resistance test is needed for these patients in order to better adapt the ARV treatment.

[Epidemiological and clinical profile of cerebral palsy at the Bobo-dioulasso university hospital (Burkina Faso)]

INTRODUCTION

Cerebral palsy is the leading cause of motor disability in children.

OBJECTIVE

To describe the epidemiological and clinical profiles of cerebral palsy in children seen at the of Bobo-Dioulasso University Hospital.

POPULATION AND METHODS

This is a descriptive cross-sectional study prospectively conducted at the Department of Physical Medicine at the University Hospital of Bobo-Dioulasso over a period of one year from 1 July 2012 to 30 June 2013. Our study population consisted of all children aged between 0 and 15 years received during the study period displaying cerebral palsy symptoms.

RESULTS

We studied 174 patients including 106 boys and 68 girls. The average age was 32.79 months. Etiological factors were dominated by prematurity (34.5%) and cerebral anoxia (25.86%). The main clinical presentations were diplegia (50%), quadriplegia (19.54%), hemiplegia (14.37%), monoplegia (10.34%) and triplegia (5.75%). The most common associated symptoms were epilepsy (15%), eye disorders (12.6%), and hearing problems (10%).

CONCLUSION

Due to its frequency and disabling potential, cerebral palsy is a major public health problem in Burkina Faso. Its support in the African environment is heavily complicated by self-medication and traditional therapy.